Robert Koch Institute, Project Group P2 (Acinetobacter baumannii - Biology of a Nosocomial Pathogen), Burgstr. 37, 38855 Wernigerode, Germany.
Robert Koch Institute, Centre for Biological Threats and Special Pathogens, ZBS 6 (Proteomics and Spectroscopy); Seestr. 10, 13353, Berlin (Wedding), Germany.
Protein Expr Purif. 2022 Nov;199:106134. doi: 10.1016/j.pep.2022.106134. Epub 2022 Jul 2.
In the last decades Acinetobacter baumannii developed into an increasingly challenging nosocomial pathogen. A. baumannii ATCC 17978 harbors a DNA-(adenine N6)-methyltransferase termed AamA. Previous studies revealed a low specific activity of AamA in vitro despite proven folding, which led us to speculate about possible interaction partners assisting AamA in targeting methylation sites. Here, applying a pulldown assay with subsequent mass spectrometry we identified aconitate hydratase 2 (AcnB) as possible interaction partner. In addition, we considered the putative transcriptional regulator gene nrdR (A1S_0220) and the pyrimidine deaminase/reductase gene ribD (A1S_0221) of A. baumannii strain ATCC 17978 to encode additional potential interaction partners due to their vicinity to the aamA gene (A1S_0222). Proteins were recombinantly produced in the milligram scale, purified to near homogeneity, and interactions with AamA were studied applying blue native gel electrophoreses, electrophoretic mobility shift assay, chemical cross-linking and co-immunoprecipitation. These analyses did not provide evidence of interaction between AamA and purified proteins. Solution structures of RibD, NrdR and AcnB were studied by small-angle X-ray scattering (SAXS) alone and in combination with AamA. While in the case of RibD and AcnB no evidence of an interaction with AamA was produced, addition of AamA to NrdR resulted in dissociation of long and rod-shaped polymeric NrdR structures, implying a specific but transient interaction. Moreover, we identified a molecular crowding effect possibly impeding the DNA methyltransferase activity in vivo and a sequence-independent DNA binding activity of AamA calling for continued efforts to identify the interaction network of AamA.
在过去的几十年中,鲍曼不动杆菌已发展成为一种越来越具有挑战性的医院病原体。鲍曼不动杆菌 ATCC 17978 携带有一种称为 AamA 的 DNA-(腺嘌呤 N6)-甲基转移酶。尽管已经证明了 AamA 的折叠,但先前的研究表明其在体外的特异性活性较低,这使我们推测可能存在协助 AamA 靶向甲基化位点的相互作用伙伴。在这里,我们应用了一种下拉测定法,随后进行了质谱分析,鉴定出了顺乌头酸水合酶 2(AcnB)作为可能的相互作用伙伴。此外,我们还考虑了鲍曼不动杆菌菌株 ATCC 17978 的假定转录调节基因 nrdR(A1S_0220)和嘧啶脱氨酶/还原酶基因 ribD(A1S_0221),因为它们靠近 aamA 基因(A1S_0222),可能编码其他潜在的相互作用伙伴。这些蛋白以毫克级规模进行重组表达,纯化至近均一性,并应用蓝色非变性凝胶电泳、电泳迁移率变动分析、化学交联和共免疫沉淀研究与 AamA 的相互作用。这些分析没有提供 AamA 与纯化蛋白之间相互作用的证据。单独和与 AamA 组合应用小角度 X 射线散射(SAXS)研究了 RibD、NrdR 和 AcnB 的溶液结构。在 RibD 和 AcnB 的情况下,没有产生与 AamA 相互作用的证据,而将 AamA 添加到 NrdR 中导致长而杆状的聚合 NrdR 结构解离,暗示存在特异性但瞬时的相互作用。此外,我们还发现了一种分子拥挤效应,可能会阻碍体内 DNA 甲基转移酶的活性,以及 AamA 的序列非依赖性 DNA 结合活性,这需要继续努力来确定 AamA 的相互作用网络。